Broadcom Inc vs Humana Inc — how do they compare? Broadcom Inc trades at $415.3 (market cap $1.98T), while Humana Inc trades at $388.05 (market cap $44.77B). The key difference: Broadcom Inc is far larger — about 44.2× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.95%). Which is the better fit depends on your goals.
| AVGO | HUM | |
|---|---|---|
Market Cap | $1.98T | $44.77B |
Sector | Technology | Health |
52-Week High | $481.57 | $409.42 |
52-Week Low | $289.60 | $163.67 |
Enterprise Value | $2.02T | $52.12B |
Dividend Yield | 0.62% | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Broadcom (AVGO) trades at $414.83, down 1.79% on the day, amid strong fundamentals including a 38.85% net income margin and consistent earnings beats. Technical analysis shows a bullish trend with key support at $412 and resistance at $422. The company reported robust cash flow from operations of $27.54 billion in 2025 and projects AI semiconductor revenue exceeding $100 billion by 2027, per CEO Hock Tan's reaffirmed forecast (The Motley Fool, 2026-08-11).
Outlook remains positive with 86% analyst buy ratings and a $510.21 consensus price target, though high valuation multiples (P/E 69.23) and competitive pressures in AI chips pose risks. The stock's growth is supported by booked AI revenue and strong cash generation, offering upside if execution continues.
Humana (HUM) trades at $388.96, up 0.9% with a neutral technical signal. The stock shows strong revenue growth reaching $129.7B in 2025 but faces margin compression with net income margin declining to 0.88%. Recent earnings beat expectations for three consecutive quarters, while analyst consensus targets $409.93. The company maintains solid cash flow generation and recently announced key leadership appointments to strengthen its Medicaid business.
Humana presents a mixed outlook with robust revenue expansion offset by margin pressures. Investment opportunity lies in Medicare Advantage growth and cost reduction initiatives, while risks include competitive pressures and regulatory changes in healthcare. Wall Street maintains cautious optimism with 39% buy ratings amid margin recovery challenges.
Trailing returns across standard periods
Latest headlines on both assets
Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.
Read more on AVGO →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →